Published: Thursday 30 July 2015
Stroke is the world’s second largest cause of death and is the number one cause of long term severe disability.
The European Commission has funded a new research project in stroke under its Horizon 2020 programme.
The PRECIOUS project will examine the consequences of treating complications of stroke such as infections or fever or swallowing problems, all of which commonly occur in elderly patients. Failing to treat these complications often leads to a worse outcome overall.
A total of 6 million Euros (over £4 million) has been awarded to the consortium to run the trial over 5 years. The project includes SAFE (Stroke Alliance for Europe) and partners from 10 other European countries. PRECIOUS will recruit 3800 patients in 80 hospitals to the study. Patients over the age of 66 will be screened and, if found suitable, will be given cheap off-the-shelf drugs in the first four days of their hospitalization.
The PRECIOUS consortium is led by Neurologist Bart van der Worp of UMC Utrecht, Netherlands. SAFE will contribute to dissemination of the project.
Jon Barrick, President of SAFE commented “Stroke research is hugely underfunded and so we are pleased to support PRECIOUS. This simple but necessary study by leading European clinicians will help inform future practice and provide better outcomes”
Coordinator Bart van der Worp on the benefits of the project:
"Our aim is that this project will demonstrate the big potential of health benefits that can be achieved for the European people - at relatively low cost. The hope is that with a preventive treatment with cheap and safe drugs the chances of good recovery after a stroke increase, both within Europe and beyond. "